These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11434313)

  • 1. Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms.
    Chang TM; Prakash S
    Mol Biotechnol; 2001 Mar; 17(3):249-60. PubMed ID: 11434313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removal.
    Prakash S; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 1998 Jan; 26(1):35-51. PubMed ID: 9507755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats.
    Prakash S; Chang TM
    Nat Med; 1996 Aug; 2(8):883-7. PubMed ID: 8705857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial cells for bioencapsulation of cells and genetically engineered E. coli. For cell therapy, gene therapy, and removal of urea and ammonia.
    Chang TM; Prakash S
    Methods Mol Biol; 1997; 63():343-58. PubMed ID: 9113661
    [No Abstract]   [Full Text] [Related]  

  • 5. Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in-vitro and in-vivo.
    Prakash S; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Sep; 28(5):397-408. PubMed ID: 11009112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial cell biotechnology for medical applications.
    Chang TM
    Blood Purif; 2000; 18(2):91-6. PubMed ID: 10838466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic rats.
    Prakash S; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):201-18. PubMed ID: 8773740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial cells with emphasis on cell encapsulation of genetically engineered cells.
    Chang TM
    Artif Organs; 1998 Nov; 22(11):958-65. PubMed ID: 9821530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells.
    Prakash S; Chang TM
    Int J Artif Organs; 2000 Jul; 23(7):429-35. PubMed ID: 10941635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered E. coli cells containing K. aerogenes gene, microencapsulated in artificial cells for urea and ammonia removal.
    Prakash S; Chang TM
    Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):629-36. PubMed ID: 8117852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uptake of nickel from industrial wastewater by genetically engineered Escherichia coli JM109].
    Deng X; Li QB; Lu YH; Sun DH; Huang YL
    Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):343-8. PubMed ID: 15969019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal.
    Prakash S; Chang TM
    Biotechnol Bioeng; 1995 Jun; 46(6):621-6. PubMed ID: 18623357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foaming of proteins: New prospects for enzyme purification processes.
    Linke D; Berger RG
    J Biotechnol; 2011 Apr; 152(4):125-31. PubMed ID: 20670663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response surface methodology for process parameter optimization of hydrogen yield by the metabolically engineered strain Escherichia coli DJT135.
    Ghosh D; Hallenbeck PC
    Bioresour Technol; 2010 Mar; 101(6):1820-5. PubMed ID: 19897361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hg2+ removal by genetically engineered Escherichia coli in a hollow fiber bioreactor.
    Chen S; Kim E; Shuler ML; Wilson DB
    Biotechnol Prog; 1998; 14(5):667-71. PubMed ID: 9758654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioaccumulation of nickel from aqueous solutions by genetically engineered Escherichia coli.
    Deng X; Li QB; Lu YH; Sun DH; Huang YL; Chen XR
    Water Res; 2003 May; 37(10):2505-11. PubMed ID: 12727263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic uses of microencapsulated genetically engineered cells.
    Chang TM; Prakash S
    Mol Med Today; 1998 May; 4(5):221-7. PubMed ID: 9612802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid artificial cells: microencapsulation of living cells.
    Chang TM
    ASAIO J; 1992; 38(2):128-30. PubMed ID: 1421607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-opting a blind watchmaker.
    Flam F
    Science; 1994 Aug; 265(5175):1032-3. PubMed ID: 7520602
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of a genetically encoded hydrogen peroxide sensor for whole cell screening of enzyme activity.
    Lim JB; Sikes HD
    Protein Eng Des Sel; 2015 Mar; 28(3):79-83. PubMed ID: 25691762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.